NCT06480188

Brief Summary

Craniocervical dystonia, characterized by symptoms distributed in the craniofacial and/or cervical regions, is a type of focal or segmental dystonia and is the most common form of dystonia in adults. Deep brain stimulation (DBS) is a significant therapeutic approach for medically refractory craniocervical dystonia. The commonly utilized DBS targets are the Globus Pallidus internus (GPi) and the Subthalamic Nucleus (STN). Current research indicates no significant difference in efficacy between these two targets, although there are some differences in the onset time, stimulation voltage, and complications. Studies utilizing magnetic resonance imaging (MRI) to assess brain activity differences in patients with dystonia have found that patients exhibit increased activity and enhanced plasticity across a broad range of brain regions, including the brainstem, cortex, subcortical structures, and the basal ganglia, among others. Consequently, an increasing number of studies are classifying dystonia within the spectrum of brain network disorders. This study aims to recruit patients with craniocervical dystonia who meet the inclusion criteria, randomly assigning them into two groups of 30 patients each. One group will receive stimulation targeting the STN, and the other will target the GPi. Using functional MRI, researcher will conduct a dynamic brain network analysis to explore the differences in the brain network mechanisms underlying the treatment of craniocervical dystonia patients between the STN and GPi targets.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 14, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 28, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

July 8, 2024

Status Verified

June 1, 2024

Enrollment Period

2.1 years

First QC Date

June 14, 2024

Last Update Submit

July 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • resting-state functional magnetic resonance imaging data

    First, all participants underwent a standardized rs-fMRI scan for data collection of resting-state BOLD signals. Secondly, data preprocessing was carried out, including head movement correction, non-brain tissue removal, temporal layer correction, spatial normalization, filtering, and removal of physiological noise. Then, the brain network was constructed based on the pre-processed data and the structural features of the brain network were identified. Finally, statistical analysis was used to compare the differences in brain network characteristics between the two groups.

    Change from baseline at 1, 6,12 months and 24 months

Secondary Outcomes (7)

  • Burke-Fahn-Marsden Scale (BFMDRS)

    Change from baseline at 1, 6,12 months and 24 months

  • Toronto West Spasmodic Torticollis Rating Scale Scale(TWSTRS)

    Change from baseline at 1, 6,12 months and 24 months

  • Craniocervical Dystonia Questionnaire

    Change from baseline at 1, 6,12 months and 24 months

  • Frenchay dysarthria scale

    Change from baseline at 1, 6,12 months and 24 months

  • Watian Drinking Experiment

    Change from baseline at 1, 6,12 months and 24 months

  • +2 more secondary outcomes

Study Arms (2)

Group A

EXPERIMENTAL

GPi-DBS group

Device: deep brain stimulation

Group B

EXPERIMENTAL

STN-DBS group

Device: deep brain stimulation

Interventions

Group A was the GPi-DBS stimulation group; Group B was the STN-DBS stimulation group

Group AGroup B

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-75 years
  • Meeting the diagnostic criteria for primary craniocervical dystonia (including patients with cranial, cervical, or unilateral extremity dystonia)
  • Disease duration ≥1 year
  • Normal cognitive function
  • The subject himself or his legal representative can sign the informed consent form

You may not qualify if:

  • Diagnosed with other neuropsychiatric diseases (Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, etc.)
  • Previous history of craniocerebral surgery
  • Major depression or anxiety
  • The presence of neurosurgical contraindications such as cerebral infarction, hydrocephalus, cerebral atrophy, and sequelae of cerebrovascular disease
  • Contraindications to CT/MRI scanning (e.g. Claustrophobia)
  • women known to be pregnant or lactating, or who had a positive pregnancy test before randomization
  • Presence of contraindications to general anesthesia (such as severe arrhythmia, severe anemia, abnormal liver and kidney function, etc.)
  • Expected survival less than 12 months
  • has participated in other interventional clinical studies that may have affected the outcome assessment
  • other circumstances considered by the investigator to be inappropriate for participation in the study or likely to pose a significant risk to the patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Ustc

Hefei, Anhui, China

RECRUITING

MeSH Terms

Conditions

Dystonia

Interventions

Deep Brain Stimulation

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Device: Deep Brain Stimulation (DBS) of Gpi,PINS G106R Device: Deep Brain Stimulation (DBS) of STN,PINS G106R
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2024

First Posted

June 28, 2024

Study Start

March 1, 2024

Primary Completion

March 31, 2026

Study Completion

March 31, 2026

Last Updated

July 8, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations